⌕
QuidelOrtho · QDEL · Nasdaq
Tenet 44 · Weak
Compare
$9.87−3.33%At closeTenet 44 · Weak
$9.87−0.34 (−3.33%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

QuidelOrtho (QDEL) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

The percentage on each card is QDEL's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

● PRNewsWireNov 16, 2026 · 10:01 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY JAN 29
QuidelOrtho (QDEL) Securities Investigation Notice - Levi & Korsinsky

QuidelOrtho shares fell roughly 14% after third-quarter 2026 results showed China revenue down 45% and respiratory revenue down 39%. Levi & Korsinsky is investigating on behalf of investors who lost money.…

QDEL −3.3% todayRead at source ↗
● PRNewsWireNov 12, 2026 · 12:15 ET
Did QuidelOrtho Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket p…

QDEL −3.3% todayRead at source ↗
● GlobeNewsWireNov 12, 2026 · 10:10 ETEARNINGS EXPECTED BY JAN 29
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving QuidelOrtho (QDEL)

Point-of-Care revenue down 27% and total sales down roughly 12% year over year: QuidelOrtho's third-quarter 2026 revenue miss against Wall Street consensus sent shares down approximately 14% Point-of-Care revenue down 27…

QDEL −3.3% todayRead at source ↗
● Business WireNov 11, 2026 · 13:38 ETCOMPANY'S OWN WORDS
QuidelOrtho Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of QuidelOrtho Corporation - QDEL

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into QuidelOr…

QDEL −3.3% todayRead at source ↗
● PRNewsWireNov 10, 2026 · 10:14 ETEARNINGS EXPECTED BY JAN 29
QDEL SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving QuidelOrtho

QuidelOrtho's May 2026 quarterly report said China's volume-based procurement program would not likely have a material impact on total annualized revenue. Third-quarter 2026 results showed China revenue down 45%, and QDE…

QDEL −3.3% todayRead at source ↗
● PRNewsWireNov 9, 2026 · 17:35 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY JAN 29
QuidelOrtho Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into QuidelOrtho (QDEL)

QuidelOrtho narrowed its full-year revenue outlook and announced a restructuring program with its third-quarter 2026 results, and shares fell roughly 14%. QDEL shareholders who lost money have rights, and Levi & Korsinsk…

QDEL −3.3% todayRead at source ↗
● Defense WorldNov 6, 2026 · 02:29 ET
QuidelOrtho Corporation (QDEL) – What Are Brokerages Thinking About This Stock?

QuidelOrtho Corporation (NASDAQ: QDEL - Get Free Report) has been assigned an average rating of "Reduce" from the six analysts that are presently covering the stock, Marketbeat Ratings reports. Two investment analysts ha…

QDEL −3.3% todayRead at source ↗
● Seeking AlphaNov 4, 2026 · 04:16 ETEARNINGS EXPECTED BY JAN 29
QuidelOrtho Corporation (QDEL) Q3 2026 Earnings Call Transcript

QuidelOrtho Corporation ( QDEL ) Q3 2026 Earnings Call November 3, 2026 5:00 PM EST Company Participants Sanjeev Sharma Brian Blaser - President, CEO & Director Micah Young - Chief Financial Officer & Principal Financial…

QDEL −3.3% todayRead at source ↗
● MarketBeatNov 3, 2026 · 21:15 ETEARNINGS EXPECTED BY JAN 29
What QuidelOrtho (QDEL) Said on Its Q3 Earnings Call

QuidelOrtho NASDAQ: QDEL reported third-quarter revenue of $619 million, down 12% year over year on a constant-currency basis, as China pricing changes and softer respiratory testing demand continued to weigh on results.…

QDEL −3.3% todayRead at source ↗
● Zacks Investment ResearchNov 3, 2026 · 18:51 ETEARNINGS EXPECTED BY JAN 29
QuidelOrtho (QDEL) Beats Q3 Earnings and Revenue Estimates

QuidelOrtho (QDEL) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.8 per share a year ago.…

QDEL −3.3% todayRead at source ↗
● PRNewsWireNov 3, 2026 · 16:05 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY JAN 29
QuidelOrtho Reports Third Quarter 2026 Financial Results

― Growth in Labs and Immunohematology Outside of China Highlights Underlying Business Strength ― ― New Cost Transformation and Enterprise Restructuring Program Expected to Deliver Over $80 Million in Annual Savings in 20…

QDEL −3.3% todayRead at source ↗
● PRNewsWireOct 29, 2026 · 15:27 ET
Transforming Data Into Actionable Insights in the Lab

SAN DIEGO, Oct. 29, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a leading global provider of diagnostic solutions, has released episode 62 of its Science Bytes podcast, exploring best practices in AI and…

QDEL −3.3% todayRead at source ↗
● PRNewsWireOct 20, 2026 · 08:00 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY JAN 29
QuidelOrtho to Report Third Quarter 2026 Financial Results on November 3, 2026

SAN DIEGO, Oct. 20, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of diagnostic solutions, announced today that it will issue a press release to report its financi…

QDEL −3.3% todayRead at source ↗
● Defense WorldOct 18, 2026 · 02:16 ETEARNINGS EXPECTED BY JAN 29
Financial Analysis: Elutia (NASDAQ:ELUT) & QuidelOrtho (NASDAQ:QDEL)

QuidelOrtho (NASDAQ: QDEL - Get Free Report) and Elutia (NASDAQ: ELUT - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength…

QDEL −3.3% todayRead at source ↗
● PRNewsWireOct 15, 2026 · 18:10 ETCOMPANY'S OWN WORDS
QuidelOrtho Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Oct. 15, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of diagnostic solutions, today announced that the Compensation Committee of the Company's Board o…

QDEL −3.3% todayRead at source ↗
● Zacks Investment ResearchOct 14, 2026 · 11:41 ETEARNINGS EXPECTED BY JAN 29
Reasons to Add QuidelOrtho Stock to Your Portfolio for Now

QDEL's strong Q2 results, diversified product portfolio and cost-saving initiatives bolster its growth prospects despite persistent weakness in respiratory demand.…

QDEL −3.3% todayRead at source ↗
● PRNewsWireOct 8, 2026 · 14:50 ET
Did QuidelOrtho Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket p…

QDEL −3.3% todayRead at source ↗
● PRNewsWireOct 7, 2026 · 07:13 ET
QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations

SAN DIEGO, Oct. 7, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of diagnostic solutions, has appointed Sanjeev Sharma, CFA, as Vice President, Investor Relations,…

QDEL −3.3% todayRead at source ↗
● Defense WorldOct 6, 2026 · 06:15 ETEARNINGS EXPECTED BY JAN 29
Contrasting QuidelOrtho (NASDAQ:QDEL) & Cooper Companies (NASDAQ:COO)

Cooper Companies (NASDAQ: COO - Get Free Report) and QuidelOrtho (NASDAQ: QDEL - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength…

QDEL −3.3% todayRead at source ↗
● PRNewsWireSep 24, 2026 · 09:12 ET
Early Intervention Aids Emergency Medicine Teams in Identifying and Personalizing Sepsis Treatment

SAN DIEGO, Sept. 24, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, is proud to share episode 61 of its Science Bytes podcast, highlighting key insights about loweri…

QDEL −3.3% todayRead at source ↗
● Defense WorldSep 16, 2026 · 04:35 ETEARNINGS EXPECTED BY JAN 29
85,251 Shares in QuidelOrtho Corporation $QDEL Purchased by Squarepoint Ops LLC

Squarepoint Ops LLC acquired a new position in QuidelOrtho Corporation (NASDAQ: QDEL) in a recent quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired…

QDEL −3.3% todayRead at source ↗
● PRNewsWireAug 27, 2026 · 09:12 ET
Faster Answers, Better Decisions: ADLM 2026 Highlights

SAN DIEGO, Aug. 27, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a leading global provider of diagnostic solutions, has released episode 60 of its Science Bytes podcast, featuring highlights from the 2026…

QDEL −3.3% todayRead at source ↗

Expected by Jan 29. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

NVDA20+3.1%
WDAY4+0.3%
CRWV3+7.0%

Article counts from the last market-wide feed page, across every symbol we track and not just QDEL · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.